Arnoni, C.P., Latini, F.R., Muniz, J.G., Gazito, D., Person, R.M., Vendrame, T.A.P., Barreto, J.A. & Castilho, L. (2014) How do we identify RHD variants using a practical molecular approach? Transfusion, 54, 962-969.
Castilho, L. & Dinardo, C.L. (2018) Optimized antigen-matched in sickle cell disease patients: chances and challenges in molecular times - the Brazilian way. Transfusion Medicine and Hemotherapy, 45, 258-262.
Chiu, R.W., Murphy, M.F., Fidler, C., Zee, B.C., Wainscoat, J.S. & Lo, Y.M. (2001) Determination of RhD zygosity: comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach. Clinical Chemistry, 47, 667-672.
Chou, S.T., Jackson, T., Vege, S., Smith-Whitley, K., Friedman, D.F. & Westhoff, C.M. (2013) High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood, 122, 1062-1071.
Chou, S.T., Evans, P., Vege, S., Coleman, S., Friedman, D.F., Keller, M. & Westhoff, C.M. (2018) Rh genotype matching for transfusion support in sickle cell disease. Blood, 132, 1198-1207.
Fasano, R.M. & Chou, S.T. (2016) Red blood cell antigen genotyping for sickle cell disease, thalassemia and other transfusion complications. Transfusion Medicine Reviews, 30, 197-201.
Frye, V., Caltabiano, M., Kessler, D.A., Schaffler, H., Reboza, M., Hillyer, C.D. & Shaz, B.H. (2014) Evaluating a program to increase blood donation among racial and ethnic minority communities in new York City. Transfusion, 54, 3061-3067.
Gaspardi, A.C., Sippert, E.A., De Macedo, M.D., Pellegrino, J. Jr., Costa, F.F. & Castilho, L. (2016) Clinically relevant RHD-CE genotypes in patients with sickle cell disease and in African Brazilian donors. Blood Transfusion, 14, 449-454.
Hipsky, C.H., Lomas-Francis, C., Fuchisawa, A. et al. (2011) RHCE*ceCF encodes partial c and partial e but not CELO, an antigen antithetical to Crawford. Transfusion, 51, 25-31.
Parra, F.C., Amado, R.C., Lambertucci, J.R., Rocha, J., Antunes, C.M. & Pena, S.D.J. (2003) Color and genomic ancestry in Brazilians. PNAS, 100, 177-182.
Rosse, W.F., Gallagher, D., Kinney, T.R., Castro, O., Dosik, H., Moohr, J., Wang, W. & Levy, P.S. (1990) Transfusion and alloimmunization in sickle cell disease. The cooperative study of sickle cell disease. Blood, 76, 1431-1437.
Schonewille, H., Haak, H.L. & van, Zijl, A.M. (1999) Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion, 39, 763-771.
Sesok-Pizzini, D.A., Friedman, D.F., Smith-Wjitley, K. & Nance, S.J. (2006) Transfusion support of patients with sickle cell disease at the Children's Hospital of Philadelphia. Immunohematology, 22, 121-125.
Singleton, B.K., Green, C.A., Avent, N.D. et al. (2000) The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood, 95, 12-18.
Sippert, E., Fujita, C.R., Machado, D. et al. (2015) Variant Rh alleles and Rh immunisation in patients with sickle cell disease. Blood Transfusion, 13, 72-77.
Sippert, E.A., Visentainer, J.E.L., Alves, H.V. et al. (2017) Red blood cell alloimmunization in patients with sickle cell disease: correlation with HLA and cytokine gene polymorphisms. Transfusion, 57, 379-389.
Wagner, F.F. & Flegel, W.A. (2000) RHD gene deletion occurred in the rhesus box. Blood, 95, 3662-3668.
Yazdanbakhsh, K., Ware, R.E. & Noizat-Pirenne, F. (2012) Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood, 120, 528-537.